Kang Hua Investment Company Limited - Net Worth and Insider Trading

Kang Hua Investment Company Limited Net Worth

The estimated net worth of Kang Hua Investment Company Limited is at least $2.4 Billion dollars as of 2025-06-05. Kang Hua Investment Company Limited is the 2501 Other of Everest Medicines Ltd and owns about 50,000,000 shares of Everest Medicines Ltd (HKSE:01952) stock worth over $2.4 Billion. Details can be seen in Kang Hua Investment Company Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kang Hua Investment Company Limited has not made any transactions after 2020-10-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Kang Hua Investment Company Limited

To

Kang Hua Investment Company Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kang Hua Investment Company Limited owns 1 companies in total, including Everest Medicines Ltd (HKSE:01952) .

Click here to see the complete history of Kang Hua Investment Company Limited’s form 4 insider trades.

Insider Ownership Summary of Kang Hua Investment Company Limited

Ticker Company Transaction Date Type of Owner
HKSE:01952 Everest Medicines Ltd 2020-10-22 2501 Other

Kang Hua Investment Company Limited Latest Holdings Summary

Kang Hua Investment Company Limited currently owns a total of 1 stock. Kang Hua Investment Company Limited owns 50,000,000 shares of Everest Medicines Ltd (HKSE:01952) as of October 9, 2020, with a value of $2.4 Billion.

Latest Holdings of Kang Hua Investment Company Limited

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01952 Everest Medicines Ltd 2020-10-09 50,000,000 47.90 2,395,000,000

Holding Weightings of Kang Hua Investment Company Limited


Kang Hua Investment Company Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Kang Hua Investment Company Limited has made a total of 2 transactions in Everest Medicines Ltd (HKSE:01952) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Everest Medicines Ltd is the sale of 50,000,000 shares on October 9, 2020, which brought Kang Hua Investment Company Limited around $0.

Insider Trading History of Kang Hua Investment Company Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kang Hua Investment Company Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kang Hua Investment Company Limited Ownership Network

Ownership Network List of Kang Hua Investment Company Limited

No Data

Ownership Network Relation of Kang Hua Investment Company Limited

Insider Network Chart


Kang Hua Investment Company Limited Owned Company Details

What does Everest Medicines Ltd do?

Who are the key executives at Everest Medicines Ltd?

Kang Hua Investment Company Limited is the 2501 Other of Everest Medicines Ltd. Other key executives at Everest Medicines Ltd include 2307 Founder of a discretionary trust who can infl Fu Wei , 2201 Interest of corporation controlled by you Nova Aqua Limited , and 2201 Interest of corporation controlled by you C-Bridge Capital GP IV, Ltd. .

Everest Medicines Ltd (HKSE:01952) Insider Trades Summary

Over the past 18 months, Kang Hua Investment Company Limited made no insider transaction in Everest Medicines Ltd (HKSE:01952). Other recent insider transactions involving Everest Medicines Ltd (HKSE:01952) include a net sale of 18,568,000 shares made by Nova Aqua Limited , a net sale of 17,100,000 shares made by Fu Wei , and a net sale of 20,520,000 shares made by C-Bridge Healthcare Fund GP II, L.P. .

In summary, during the past 3 months, insiders sold 0 shares of Everest Medicines Ltd (HKSE:01952) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 193,000,000 shares of Everest Medicines Ltd (HKSE:01952) were sold and 0 shares were bought by its insiders, resulting in a net sale of 193,000,000 shares.

Everest Medicines Ltd (HKSE:01952)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Everest Medicines Ltd Insider Transactions

No Available Data

Kang Hua Investment Company Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Kang Hua Investment Company Limited. Currently GuruFocus does not have mailing address information for Kang Hua Investment Company Limited.